Cargando…

Benefits and Prerequisites Associated with the Adoption of Oral 3D-Printed Medicines for Pediatric Patients: A Focus Group Study among Healthcare Professionals

The utilization of three-dimensional (3D) printing technologies as innovative manufacturing methods for drug products has recently gained growing interest. From a technological viewpoint, proof-of-concept on the performance of different printing methods already exist, followed by visions about futur...

Descripción completa

Detalles Bibliográficos
Autores principales: Rautamo, Maria, Kvarnström, Kirsi, Sivén, Mia, Airaksinen, Marja, Lahdenne, Pekka, Sandler, Niklas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150973/
https://www.ncbi.nlm.nih.gov/pubmed/32150899
http://dx.doi.org/10.3390/pharmaceutics12030229
_version_ 1783521142231793664
author Rautamo, Maria
Kvarnström, Kirsi
Sivén, Mia
Airaksinen, Marja
Lahdenne, Pekka
Sandler, Niklas
author_facet Rautamo, Maria
Kvarnström, Kirsi
Sivén, Mia
Airaksinen, Marja
Lahdenne, Pekka
Sandler, Niklas
author_sort Rautamo, Maria
collection PubMed
description The utilization of three-dimensional (3D) printing technologies as innovative manufacturing methods for drug products has recently gained growing interest. From a technological viewpoint, proof-of-concept on the performance of different printing methods already exist, followed by visions about future applications in hospital or community pharmacies. The main objective of this study was to investigate the perceptions of healthcare professionals in a tertiary university hospital about oral 3D-printed medicines for pediatric patients by means of focus group discussions. In general, the healthcare professionals considered many positive aspects and opportunities in 3D printing of pharmaceuticals. A precise dose as well as personalized doses and dosage forms were some of the advantages mentioned by the participants. Especially in cases of polypharmacy, incorporating several drug substances into one product to produce a polypill, personalized regarding both the combination of drug substances and the doses, would benefit drug treatments of several medical conditions and would improve adherence to medications. In addition to the positive aspects, concerns and prerequisites for the adoption of 3D printing technologies at hospital settings were also expressed. These perspectives are suggested by the authors to be focus points for future research on personalized 3D-printed drug products.
format Online
Article
Text
id pubmed-7150973
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-71509732020-04-20 Benefits and Prerequisites Associated with the Adoption of Oral 3D-Printed Medicines for Pediatric Patients: A Focus Group Study among Healthcare Professionals Rautamo, Maria Kvarnström, Kirsi Sivén, Mia Airaksinen, Marja Lahdenne, Pekka Sandler, Niklas Pharmaceutics Article The utilization of three-dimensional (3D) printing technologies as innovative manufacturing methods for drug products has recently gained growing interest. From a technological viewpoint, proof-of-concept on the performance of different printing methods already exist, followed by visions about future applications in hospital or community pharmacies. The main objective of this study was to investigate the perceptions of healthcare professionals in a tertiary university hospital about oral 3D-printed medicines for pediatric patients by means of focus group discussions. In general, the healthcare professionals considered many positive aspects and opportunities in 3D printing of pharmaceuticals. A precise dose as well as personalized doses and dosage forms were some of the advantages mentioned by the participants. Especially in cases of polypharmacy, incorporating several drug substances into one product to produce a polypill, personalized regarding both the combination of drug substances and the doses, would benefit drug treatments of several medical conditions and would improve adherence to medications. In addition to the positive aspects, concerns and prerequisites for the adoption of 3D printing technologies at hospital settings were also expressed. These perspectives are suggested by the authors to be focus points for future research on personalized 3D-printed drug products. MDPI 2020-03-05 /pmc/articles/PMC7150973/ /pubmed/32150899 http://dx.doi.org/10.3390/pharmaceutics12030229 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Rautamo, Maria
Kvarnström, Kirsi
Sivén, Mia
Airaksinen, Marja
Lahdenne, Pekka
Sandler, Niklas
Benefits and Prerequisites Associated with the Adoption of Oral 3D-Printed Medicines for Pediatric Patients: A Focus Group Study among Healthcare Professionals
title Benefits and Prerequisites Associated with the Adoption of Oral 3D-Printed Medicines for Pediatric Patients: A Focus Group Study among Healthcare Professionals
title_full Benefits and Prerequisites Associated with the Adoption of Oral 3D-Printed Medicines for Pediatric Patients: A Focus Group Study among Healthcare Professionals
title_fullStr Benefits and Prerequisites Associated with the Adoption of Oral 3D-Printed Medicines for Pediatric Patients: A Focus Group Study among Healthcare Professionals
title_full_unstemmed Benefits and Prerequisites Associated with the Adoption of Oral 3D-Printed Medicines for Pediatric Patients: A Focus Group Study among Healthcare Professionals
title_short Benefits and Prerequisites Associated with the Adoption of Oral 3D-Printed Medicines for Pediatric Patients: A Focus Group Study among Healthcare Professionals
title_sort benefits and prerequisites associated with the adoption of oral 3d-printed medicines for pediatric patients: a focus group study among healthcare professionals
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150973/
https://www.ncbi.nlm.nih.gov/pubmed/32150899
http://dx.doi.org/10.3390/pharmaceutics12030229
work_keys_str_mv AT rautamomaria benefitsandprerequisitesassociatedwiththeadoptionoforal3dprintedmedicinesforpediatricpatientsafocusgroupstudyamonghealthcareprofessionals
AT kvarnstromkirsi benefitsandprerequisitesassociatedwiththeadoptionoforal3dprintedmedicinesforpediatricpatientsafocusgroupstudyamonghealthcareprofessionals
AT sivenmia benefitsandprerequisitesassociatedwiththeadoptionoforal3dprintedmedicinesforpediatricpatientsafocusgroupstudyamonghealthcareprofessionals
AT airaksinenmarja benefitsandprerequisitesassociatedwiththeadoptionoforal3dprintedmedicinesforpediatricpatientsafocusgroupstudyamonghealthcareprofessionals
AT lahdennepekka benefitsandprerequisitesassociatedwiththeadoptionoforal3dprintedmedicinesforpediatricpatientsafocusgroupstudyamonghealthcareprofessionals
AT sandlerniklas benefitsandprerequisitesassociatedwiththeadoptionoforal3dprintedmedicinesforpediatricpatientsafocusgroupstudyamonghealthcareprofessionals